With the common efforts, Creative Biolabs is proud to bring out the unique Monoclonal Guinea Pig Antibody Production service for researchers all over the world. In other words, global customers can now get monoclonal guinea pig antibodies with high specificity and antibody affinity for their research.
Compared with other rodents, guinea pigs are more sensitivity, which provides an important feature in the study of human diseases. In addition, the difference of genotype enables guinea pig to generate stronger antibody response to some antigens that are high homology with humans, mouse and rats.
Based on the progress of guinea pig related research, Creative Biolabs can provide novel monoclonal our well-recognized phage display technology. After routine immunization strategy, our scientists are confident in generating high diversity phage display guinea pig antibody libraries and isolate high specific and affinity monoclonal guinea pig antibodies using biopanning techniques, such as antibody panning.
In addition, Creative Biolabs also provides the unique Native™ Guinea Pig Antibody Discovery Service based on antigen-specific B lymphocytes cytometry technology and Guinea Pig Hybridoma Development Service. We can customize guinea pig antibodies with different technologies according to your specific demands.
“With years of experience in monoclonal antibody structure research, we are sure to be the right choice for you in generating the desired monoclonal antibodies”, introduced Dr, Monika, chief scientific officer of Creative Biolabs. He also recommends customers to contact them at info@creative-biolabs.com or call 1-631-871-5806 for details.
About Creative Biolabs
Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early antibody drug discovery and development. As a trusted provider of the most cost-effective outsourcing solutions, Creative Biolabs has been working for a large number of satisfied clients from biotechnology and pharmaceutical companies as well as government and academic research laboratories all over the world.
